Trulieve Cannabis Corp. (OTCMKTS: TCNNF) is a vertically integrated cannabis company primarily engaged in the cultivation, processing, manufacturing and retail distribution of medical cannabis products. Headquartered in Tallahassee, Florida, Trulieve operates a network of dispensaries that serve patients through proprietary brands as well as third-party producer lines. The company’s product offering spans flower, concentrates, vaporizers, edibles, tinctures, capsules and topicals, all of which are developed in its in-house laboratories and processing facilities.
Since opening its first dispensary in 2015, Trulieve has expanded its footprint across multiple U.S. states, leveraging state licenses and acquisition strategies to broaden market access. In addition to its strong presence in Florida, the company has established operations in Arizona, California, Massachusetts, Pennsylvania and Connecticut. Trulieve’s vertically integrated model allows it to control the supply chain—from seed-to-sale—ensuring consistent product quality and regulatory compliance in each jurisdiction it serves.
Trulieve’s leadership team is led by Chief Executive Officer Kim Rivers, who has overseen the company’s transformation into one of the largest medical cannabis operators in the United States. Rivers, a seasoned executive with a legal background in intellectual property and government regulation, has guided Trulieve through regulatory challenges and strategic acquisitions. The executive team also includes professionals with deep experience in cultivation, retail operations, finance and regulatory affairs.
Over the years, Trulieve has pursued a growth strategy that combines organic expansion with targeted acquisitions, aiming to strengthen its retail presence and diversify its product portfolio. The company continues to invest in cultivation and processing infrastructure, research and development initiatives, and patient education programs. With a focus on operational efficiency and patient care, Trulieve seeks to capitalize on evolving medical cannabis markets and regulatory developments across the United States.
AI Generated. May Contain Errors.
